ClinicalTrialsFinder

Renal Cell Carcinoma, Clear Cell Clinical Trials in Beijing

1 recruitingBeijing, China

Showing 1–1 of 1 trials

Recruiting
Not Applicable

Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy

Renal Cell Carcinoma, Clear Cell, Somatic
Peking University First Hospital36 enrolled1 locationNCT06317298